A Hybrid Approach to Decentralized Trials
Featured in Clinical Researcher: Scott Gray, CEO discusses the importance of a hybrid approach to decentralized trials for patients with rare diseases.
patient retention
Rare Disease Trial Participants Need Extra Support and Assistance, Survey Shows
Featured on CenterWatch.com: Newly published results from a survey, conducted by the patient support service company Clincierge, found that 95 percent of the trial participants responded and 98 percent of their caregivers considered it essential to have a single point of contact to help them throughout a trial, especially when arranging travel plans.
Practical Tips to Boost Clinical Trial Participation and Retention
Featured on ACRPnet.org: Looking for ways to increase participation in your clinical trials? First, stop calling participants “subjects,” says Scott Gray, CEO of Clincierge, whose organization just released a research report, “Voice of the Patient,” examining the patient experience in clinical trials of rare diseases. “They are volunteers, they are human beings,” Gray says.
Clincierge Releases Study on Patient Experience in Clinical Trials
PHILADELPHIA and SAN DIEGO, June 14, 2022 /PRNewswire/ — Clincierge today released “Voice of the Patient,” a research report examining the patient experience in clinical trials of rare diseases, at the 2022 BIO International Convention in San Diego, California.
The Company Bringing Patients to Clinical Trials
Featured in Drug Discovery World: DDW’s Reece Armstrong speaks to Scott Gray, President & CEO of Clincierge about its unique approach to improving the clinical trial experience for patients.
BIO Panel Takes on Patient Recruitment, Retention Challenges
During BIO International, a group of industry experts discussed patient recruitment and retention challenges in the panel discussion Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials on Monday, June 13. Outsourcing-Pharma spoke with Clincierge CEO Scott Gray, the moderator of the talk, to get a sneak peek at the session.
The ‘Voice of the Patient’ Needs to be Heard in Clinical Trials: Study
Featured in The Science Advisory Board: Patient recruitment and retention are among the biggest challenges facing clinical research, particularly in studies targeting rare diseases that have a limited pool of patients, contends Clincierge CEO Scott Gray. At the 2022 Biotechnology Innovation Organization (BIO) International Convention, Clincierge will release the results of an independent, institutional review …
The ‘Voice of the Patient’ Needs to be Heard in Clinical Trials: Study Read More »
Clincierge to Host Patient Experience Panel at BIO International 2022
PHILADELPHIA, June 2, 2022 /PRNewswire/ — Clincierge today announced CEO Scott Gray will moderate Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials at the upcoming 2022 BIO International Convention on June 13-16, 2022, in San Diego, California.
Advancing Clinical Trials with Patient Support
Featured in Pharmaceutical Outsourcing: Losing a single patient during a clinical trial can mean giving up crucial data and extending trial timelines, often resulting in significant financial repercussions for trial sponsors and their research partners.
Recruiting and Retaining Diverse Patient Populations for Clinical Trials
In this Summer 2021 issue of InSite, The Global Journal for Clinical Research Sites, we leverage our Global Impact Partnership with Society for Clinical Research Sites to address practical steps to recruit and retain diverse patient populations in clinical trials.
